Last Modified: January 27, 2021
Est. Read Time: 3 min read
Fact Checked
Expert Verified

Our content is developed and backed by respected legal, medical and scientific experts. More than 30 contributors, including product liability attorneys and board-certified physicians, have reviewed our website to ensure it’s medically sound and legally accurate.

Why Trust Drugwatch?
Drugwatch is trusted
legal help when you need it most.

Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by Wilson & Peterson LLP, we've pursued justice for more than 20,000 families and secured $324 million in settlements and verdicts against negligent manufacturers.

More than 30 contributors, including mass tort attorneys and board-certified doctors, have reviewed our website and added their unique perspectives to ensure you get the most updated and highest quality information.

Drugwatch.com is AACI-certified as a trusted medical content website and is produced by lawyers, a patient advocate and award-winning journalists whose affiliations include the American Bar Association and the American Medical Writers Association.

About Drugwatch.com

  • 15+ Years of Advocacy
  • $324 Million Recovered for Clients
  • 20,000 Families Helped
  • A+ BBB Rating
  • 4.9 Stars from Google Reviews
Learn More About Us

Testimonials

I found Drugwatch to be very helpful with finding the right lawyers. We had the opportunity to share our story as well, so that more people can be aware of NEC. We are forever grateful for them.
Chasity P. Legal Client
  • Google Business Rating
  • BBB A+ Rating Logo

In her 45 years as a Type 1 diabetic, Gail deVore has seen the price of insulin skyrocket to $350 per bottle.

“I remember paying $75 a bottle. I remember paying $50 a bottle. I remember paying $35 a bottle,” the 56-year-old Denver resident said. “When you’re getting your prescription filled and suddenly it’s costing you double, you walk away from the pharmacy scratching your head trying to make sense of what they just told you. But there’s nothing you can do. Seriously, what can we do?”

Doctors diagnosed deVore with Type 1 diabetes in 1972. People with Type 1 diabetes must take insulin to keep their blood sugar levels in a healthy range. The cost of treatment differs depending on how much insulin a patient requires. For some people, one $350 bottle of insulin can last two weeks if used as prescribed. For others, the same amount is gone in five days.

“There is no other treatment — absolutely no other treatment — you will die without insulin,” deVore said. “I wish the world would wake up and understand that … this is what keeps us alive. And if we can’t afford it, we die. Period. There is no getting around that fact. So, why can’t there be some [cost] control?”

Sign Patients for Affordable Drugs’ petition to tell Congress to let Medicare negotiate lower drug prices. Our Partners

Our Trusted Legal Partners

Drugwatch partners with trusted law firms to help you take legal action. After submitting the form, one of Drugwatch's partners will contact you for a free case review.

simmons hanly conroy law firm logo weitz and luxenberg logo sokolove law firm logo levin papantonio rafferty law firm logo nigh goldenberg raso and vaughn law firm logo morgan & morgan logo the ferraro law firm logo meirowitz & wasserberg law firm logo

‘A Club Nobody Wants to Belong To’

deVore requires a 24-hour-a-day infusion pump that continuously pushes insulin into her body. By today’s pricing, deVore estimates it would cost her about $3,000 to stay alive on a monthly basis without insurance. Like many diabetics in the U.S., deVore at times has found her prescriptions to be out of reach.

Gail Insulin Pump
Gail deVore shows where an infusion set is attached to her body. She is required to put in a new infusion set every other day

“I knew that I was running very low on pump supplies, and I knew my budget just wouldn’t stretch far enough to cover purchasing them outside of insurance or even with insurance because you still have deductibles, you still have co-pays,” she recalled. “My emotional state at that time was more like: ‘OK, here’s another problem.’”

deVore turned to a California-based nonprofit for help getting the supplies she needed.

“I think for some people it’s probably very humiliating to have to ask for help,” she said. “I’ve been diabetic for so long that I’ve lost that inhibition to say, ‘Hey, I need help.’ You have to rely on the kindness of strangers to help you out and that is very humbling.”

The communities deVore is affiliated with of Type 1 diabetics and their families are “incredible, lovely, helpful, welcoming,” she said.

“It’s a club nobody wants to belong to but thank God we belong to a community like this,” deVore said.

Insulin Patent Sold for $1

Looking at the price of insulin today, it’s hard to believe insulin’s discoverers sold their patent for $1.

“They did that intentionally — so that we could always afford insulin,” deVore said. “We’re at 96 years of insulin being available for people to be able to treat their Type 1 diabetes and look at what it costs us. People die. They can’t afford it — they die. They go without. The length that people go to to have to stay alive — it’s unbelievable, it’s mindboggling.”

No Generic Options

One reason insulin prices are so high is because there are no generic options.

“Everything else that I take — run-of-the-mill things — all come in generics, and the price of one of those prescriptions might be $20 for a 90-day supply,” deVore said. “We need something so that we have options.”

It wasn’t until recently that deVore learned the government does not regulate drug prices.

“Here I am 45 years of Type 1 never knowing until recently that oh you mean pharmaceutical pricing isn’t regulated — really?” she said. “Wow!”

Disclaimer: Thoughts and opinions expressed in this patient story are strictly anecdotal and should not be taken as medical information or advice. Views of the interviewee do not necessarily reflect those of the author, editor or Drugwatch.